Literature DB >> 34268498

ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment.

Giada Bianchi1, Peter G Czarnecki2, Matthew Ho3,4, Aldo M Roccaro5, Antonio Sacco5, Yawara Kawano6, Annamaria Gullà7, Anil Aktas Samur8, Tianzeng Chen3, Kenneth Wen7, Yu-Tzu Tai7, Maria Moscvin3, Xinchen Wu9, Gulden Camci-Unal9, Matteo C Da Vià10, Niccolo' Bolli10,11, Tomasz Sewastianik12,13, Ruben D Carrasco12, Irene M Ghobrial7, Kenneth C Anderson7.   

Abstract

The bone marrow (BM) microenvironment actively promotes multiple myeloma (MM) pathogenesis and therapies targeting both cancer cells and the niche are highly effective. We were interested in identifying novel signaling pathways supporting MM-BM crosstalk. Mutations in the transmembrane receptor Roundabout 1 (ROBO1) were recently identified in MM patients, however their functional consequences are uncertain. Through protein structure-function studies, we discovered that ROBO1 is necessary for MM adhesion to BM stromal and endothelial cells and ROBO1 knock out (KO) compromises BM homing and engraftment in a disseminated mouse model. ROBO1 KO significantly decreases MM proliferation in vitro and intra- and extramedullary tumor growth, in vivo. Mechanistically, ROBO1 C-terminus is cleaved in a ligand-independent fashion and is sufficient to promote MM proliferation. Viceversa, mutants lacking the cytoplasmic domain, including the human-derived G674* truncation, act dominantly negative. Interactomic and RNA sequencing studies suggest ROBO1 may be involved in RNA processing, supporting further studies.

Entities:  

Keywords:  bone marrow microenvironment; dissemination; multiple myeloma; pathogenesis; transmembrane receptor

Mesh:

Substances:

Year:  2021        PMID: 34268498      PMCID: PMC8265993          DOI: 10.1158/2643-3230.BCD-20-0164

Source DB:  PubMed          Journal:  Blood Cancer Discov        ISSN: 2643-3230


  27 in total

Review 1.  The bone-marrow niche in MDS and MGUS: implications for AML and MM.

Authors:  Irene M Ghobrial; Alexandre Detappe; Kenneth C Anderson; David P Steensma
Journal:  Nat Rev Clin Oncol       Date:  2018-01-09       Impact factor: 66.675

2.  Cables links Robo-bound Abl kinase to N-cadherin-bound beta-catenin to mediate Slit-induced modulation of adhesion and transcription.

Authors:  Jinseol Rhee; Tim Buchan; Lawrence Zukerberg; Jack Lilien; Janne Balsamo
Journal:  Nat Cell Biol       Date:  2007-07-08       Impact factor: 28.824

3.  The Adam family metalloprotease Kuzbanian regulates the cleavage of the roundabout receptor to control axon repulsion at the midline.

Authors:  Hope A Coleman; Juan-Pablo Labrador; Rebecca K Chance; Greg J Bashaw
Journal:  Development       Date:  2010-07       Impact factor: 6.868

4.  Differential and limited expression of mutant alleles in multiple myeloma.

Authors:  Naim U Rashid; Adam S Sperling; Niccolo Bolli; David C Wedge; Peter Van Loo; Yu-Tzu Tai; Masood A Shammas; Mariateresa Fulciniti; Mehmet K Samur; Paul G Richardson; Florence Magrangeas; Stephane Minvielle; P Andrew Futreal; Kenneth C Anderson; Herve Avet-Loiseau; Peter J Campbell; Giovanni Parmigiani; Nikhil C Munshi
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

5.  Cell-surface heparan sulfate is involved in the repulsive guidance activities of Slit2 protein.

Authors:  H Hu
Journal:  Nat Neurosci       Date:  2001-07       Impact factor: 24.884

6.  Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance.

Authors:  K Brose; K S Bland; K H Wang; D Arnott; W Henzel; C S Goodman; M Tessier-Lavigne; T Kidd
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

7.  Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.

Authors:  Michael C Gundry; Lorenzo Brunetti; Angelique Lin; Allison E Mayle; Ayumi Kitano; Dimitrios Wagner; Joanne I Hsu; Kevin A Hoegenauer; Cliona M Rooney; Margaret A Goodell; Daisuke Nakada
Journal:  Cell Rep       Date:  2016-10-25       Impact factor: 9.423

Review 8.  Mouse models of multiple myeloma: technologic platforms and perspectives.

Authors:  Marco Rossi; Cirino Botta; Mariamena Arbitrio; Rosa Daniela Grembiale; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Oncotarget       Date:  2018-04-13

9.  Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database.

Authors:  Muhammad Umar Jawad; Sean P Scully
Journal:  J Hematol Oncol       Date:  2009-09-24       Impact factor: 17.388

10.  Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes.

Authors:  Feng Xu; Ling-Yun Wu; Chun-Kang Chang; Qi He; Zheng Zhang; Li Liu; Wen-Hui Shi; Juan Guo; Yang Zhu; You-Shan Zhao; Shu-Cheng Gu; Cheng-Ming Fei; Dong Wu; Li-Yu Zhou; Ji-Ying Su; Lu-Xi Song; Chao Xiao; Xiao Li
Journal:  Nat Commun       Date:  2015-11-26       Impact factor: 14.919

View more
  3 in total

1.  Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma.

Authors:  Liping Lin; Xuan Wu; Yuanxue Jiang; Caijiu Deng; Xi Luo; Jianjun Han; Jiazhu Hu; Xiaolong Cao
Journal:  PeerJ       Date:  2022-05-24       Impact factor: 3.061

Review 2.  Molecular Impact of the Tumor Microenvironment on Multiple Myeloma Dissemination and Extramedullary Disease.

Authors:  Stefan Forster; Ramin Radpour
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

3.  Tumor immune cell infiltration score based model predicts prognosis in multiple myeloma.

Authors:  Can Chen; Yiwei Li; Peiwen Miao; Ying Xu; Yaping Xie; Zhenzhen Chen; Shenxian Qian
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.